Biotech Firm Raises $180 Million to Fund Late-Stage Trials
The raise will fund Phase III trials for the company's lead oncology candidate through to results.
1 Aug 2026
Capital raisings, IPOs, investing, wealth and super — how Australian money is raised, allocated and grown.
The $340 million raise will fund a processing plant expansion at the company's flagship project.